M. Oliver

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Michael Francis Oliver, Michael F. Oliver, M. Oliver, M Oliver, M. F Oliver, M. F. Oliver, Michael F Oliver, M.f Oliver, Michael Oliver, M.f. Oliver, M F Oliver
Publication record
356 papers · 12,801 citations · H-index 57

PAPERS

Fatty acids and the risk of death during acute myocardial ischaemia.
201526 citationsauthor #1
Fatty acids and recovery during first hours of acute myocardial ischemia.
20143 citationsauthor #1
Res Medica, April 1967, Special Issue – Lauder Brunton Centenary Symposium on Angina Pectoris
20142 citationsauthor #12
Is Angina Preventable
20140 citationsauthor #1
The clofibrate saga: a retrospective commentary.
201229 citationsauthor #1
Free fatty acids and acute coronary syndromes--the history.
20111 citationsauthor #1
Choosing references.
20100 citationsauthor #1
Cholesterol-lowering and cancer in the prevention of cardiovascular disease.
20104 citationsauthor #1
Control of free fatty acids during acute myocardial ischaemia
201025 citationsauthor #1
Lipid lowering and ischaemic heart disease.
20096 citationsauthor #1
Metabolic aspects of rhythm disturbances.
200912 citationsauthor #4
The effect of antilipolytic agents on cyclic AMP, free fatty acid and total catecholamine concentrations in plasma.
20099 citationsauthor #4
Strategies for preventing coronary heart disease.
20092 citationsauthor #1
What are we trying to prevent--coronary atherosclerosis or ischaemic heart disease?
20092 citationsauthor #1
Histocompatibility antigens and myocardial infarction.
20088 citationsauthor #2
Th-S17:3 Early emerging studies of the atherogenicity of lipoproteins (a European perspective)
20060 citationsauthor #1
linoleic acid intake . Duodenal ulcer is associated with low dietary
20060 citationsauthor #4
Sudden cardiac death: the lost fatty acid hypothesis.
200672 citationsauthor #1
Evidence-based Cardiology Management of hyperlipidaemia
20051 citationsauthor #1
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.
2005207 citationsauthor #7
View Quantitative Coronary Angiography to Measure Progression and Regression of Coronary Atherosclerosis Value, Limitations, and Implications for Clinical Trials
20050 citationsauthor #6
,An Official Journalof the CArerican Heart cAssociation, Inc. Prevention of coronary heart disease propaganda, promises, problems, and prospects
20050 citationsauthor #1
1117-88 High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: Results from the MIRACL trial
20040 citationsauthor #5
Lower patient's cholesterol now. Trial evidence shows clear benefits from secondary prevention. 1995.
20041 citationsauthor #1
Sudden unexpected cardiac death.
20023 citationsauthor #1
Statins and stroke: evidence for cholesterol-independent effects.
200292 citationsauthor #3
Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy
2002191 citationsauthor #5
Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes.
200290 citationsauthor #1
Stroke reduction with atorvastatin in acute coronary syndromes : Results of the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) trial
20012 citationsauthor #4
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.
20011,621 citationsauthor #5
Atorvastatin for acute coronary syndromes.
20015 citationsauthor #5
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
20011,151 citationsauthor #5
Prevention of Ventricular Fibrillation During Acute Myocardial Ischemia: Control of Free Fatty Acids
200114 citationsauthor #1
Antilipolytic drugs for the prevention of primary ventricular fibrillation
20014 citationsauthor #1
The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Trial: Effects of Intensive Atorvastatin Treatment on Early Recurrent Events After an Acute Coronary Syndrome
20008 citationsauthor #5
Cholesterol and strokes
200029 citationsauthor #1
Pioneer research in Britain into atherosclerosis and coronary heart disease--an historical review.
200011 citationsauthor #1
Atherosclerosis Research after the Second World War
20000 citationsauthor #1
ect of an á 2 agonist ( mivazerol ) on limiting myocardial ischaemia in stable angina
19990 citationsauthor #4
Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT).
1999203 citationsauthor #1
The atheromatous lipid core.
19989 citationsauthor #1
Cholesterol lowering diets and coronary heart disease. Advice should now be to increase intake of vegetable oils and fish.
19980 citationsauthor #1
Fibrinogen and coronary heart disease--what does it mean?
19980 citationsauthor #1
It is more important to increase the intake of unsaturated fats than to decrease the intake of saturated fats: evidence from clinical trials relating to ischemic heart disease.
199754 citationsauthor #1
Should we treat hypercholesterolaemia in patients over 65?
19976 citationsauthor #1
Relation of plaque lipid composition and morphology to the stability of human aortic plaques.
1997274 citationsauthor #4
The low fat/low cholesterol diet is ineffective.
199719 citationsauthor #2
Any questions: Use of a statin for reducing cholesterol levels
19970 citationsauthor #1
Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors.
1997195 citationsauthor #6
Trial by ordeal in clinical research.
19960 citationsauthor #1
Which changes in diet prevent coronary heart disease? A review of clinical trials of dietary fats and antioxidants.
19966 citationsauthor #1
Lowering cholesterol for primary prevention of coronary heart disease: Extrapolation beyond the facts?
19960 citationsauthor #1
Multicentre anti-atheroma study
19950 citationsauthor #1
Antioxidant nutrients, atherosclerosis, and coronary heart disease.
199535 citationsauthor #1
Dietary polyunsaturated fatty acids and aortic plaques
19953 citationsauthor #7
Lower patients' cholesterol now
199540 citationsauthor #1
Detection and treatment of mild/moderate hypercholesterolemia is clearly beneficial for the prevention of coronary disease: antagonist's opinion.
19940 citationsauthor #1
Ischaemic heart disease and cholesterol ... and mislead on adverse effects.
19940 citationsauthor #3
Mivazerol, an α2-adrenoceptor agonist, improves exercise induced ischaemia in patients with angina pectoris
19943 citationsauthor #4
Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men.
199445 citationsauthor #5
State-of-the-art symposia abstractEffect of 4 years' simvastatin therapy on coronary atherosclerosis
19940 citationsauthor #1
Dietary polyunsaturated fatty acids and composition of human aortic plaques.
199471 citationsauthor #4
Insulin resistance syndrome as afeature of cardiological syndrome X innon-obese men
19940 citationsauthor #3
A ONE‐YEAR MULTICENTRE STUDY OF SIMVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
19942 citationsauthor #63
Insulin resistance in chronic heart failure.
1994136 citationsauthor #6
Blood cholesterol is causally related to atherosclerosis.
19940 citationsauthor #1
Lowering cholesterol for prevention of coronary heart disease--problems and perspectives.
19931 citationsauthor #1
National cholesterol policies.
19936 citationsauthor #1
HOW SOUND ARE RECOMMENDATIONS FOR LOWERING CHOLESTEROL FOR THE PRIMARY PREVENTION OF CORONARY HEART DISEASE?
19930 citationsauthor #1
Exercise tolerance in angina is improved by mivazerol—An alpha2-adrenoceptor agonist
19939 citationsauthor #4
Lowering cholesterol for prevention of coronary heart disease—Problems and perspectives
19932 citationsauthor #1
Cholesterol and coronary disease —Outstanding questions
199211 citationsauthor #1
Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men.
199257 citationsauthor #5
Doubts about preventing coronary heart disease.
1992111 citationsauthor #1
Implications of regression trials for clinical practice
19920 citationsauthor #1
Is cholesterol reduction always safe?
19927 citationsauthor #1
Inverse Relationship Between Serum Lp(a) Levels and First-Phase Insulin Secretion
199229 citationsauthor #6
Cholesterol and coronary disease--outstanding questions.
19921 citationsauthor #1
Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men.
199266 citationsauthor #5
The cholesterol controversy.
19923 citationsauthor #1
New horizons in the pathogenesis of coronary heart disease
19923 citationsauthor #1
Lipids and coronary disease--resolved and unresolved problems.
19917 citationsauthor #1
Anti-oxidants and pro-oxidants in coronary heart disease.
199121 citationsauthor #6
Relationships of Plasma Viscosity, Coagulation and Fibrinolysis to Coronary Risk Factors and Angina
1991138 citationsauthor #10
Exercise-induced myocardial ischaemia in men with angina is improved by a new compound with alpha-2 adrenoceptor agonist activity
19911 citationsauthor #3
Lipids: Outstanding Questions
19910 citationsauthor #1
'Might reduction of plasma cholesterol imperil cell physiology?'.
19916 citationsauthor #1
Sex difference in presynaptic adrenergic inhibition of norepinephrine release during normoxia and ischemia in the rat heart.
199152 citationsauthor #4
Duodenal ulcer is associated with low dietary linoleic acid intake.
199034 citationsauthor #4
Effects of safflower oil and evening primrose oil in men with a low dihomo-gamma-linolenic level.
19906 citationsauthor #5
Cholesterol and coronary heart disease — the pros and cons for action
19900 citationsauthor #1
Lowering cholesterol concentrations and mortality
199020 citationsauthor #1
Failure of the cholinergic modulation of norepinephrine release during acute myocardial ischemia in the rat.
199015 citationsauthor #4
Effects of safflower oil and evening primrose oil in men with a low dihomo-γ-linolenic level
199012 citationsauthor #5
Introduction: lipids and coronary disease--resolved and unresolved problems.
199022 citationsauthor #1
Linoleic acid, antioxidants and coronary heart disease.
199012 citationsauthor #1
Risk factors for coronary heart disease in middle aged men.
19900 citationsauthor #5
Low Plasma Vitamins E and C Increased Risk of Angina in Scottish Men a
198969 citationsauthor #6
Effect of pindolol versus atenolol on lipid profile in hypertensive patients.
19899 citationsauthor #4
Crisis in cardiovascular research in Britain.
19894 citationsauthor #1

TIMELINE

1953 126 citations

1954 54 citations

1955 138 citations

1956 218 citations

1957 78 citations

1958 31 citations

1959 294 citations

1960 205 citations

1961 257 citations

1962 22 citations

1963 253 citations

1964 40 citations

1965 75 citations

1966 162 citations

1967 188 citations

1968 843 citations

1969 246 citations

1970 425 citations

1971 362 citations

1972 520 citations

1973 0 citations

1974 167 citations

1975 196 citations

1976 478 citations

1977 78 citations

1978 351 citations

1979 174 citations

1980 9 citations

1981 189 citations

1982 183 citations

1983 27 citations

1984 103 citations

1985 89 citations

1986 234 citations

1987 279 citations

1988 96 citations

1989 226 citations

1990 121 citations

1991 225 citations

1992 288 citations

1993 18 citations

1994 257 citations

1995 78 citations

1996 6 citations

1997 548 citations

1998 9 citations

1999 203 citations

2000 48 citations

2001 2,797 citations

2002 376 citations

2004 1 citations

2005 208 citations

2006 72 citations

2008 8 citations

2009 31 citations

2010 29 citations

2011 1 citations

2012 29 citations

2014 5 citations

2015 26 citations

Unknown 0 citations

M. Oliver

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT